A related editorial discusses the findings of this study, suggesting patients with atrial fibrillation who sustain a hemorrhagic stroke or traumatic intracranial hemorrhage have different prognoses, and recommendations for resuming oral anticoagulant treatment should consider this difference. Further larger randomised controlled trials are needed to provide definitive guidance.